Predictors of Time to Discontinuation of Levodopa-Carbidopa Intestinal Gel Infusion: A Retrospective Cohort Study

BACKGROUND: Continuous intra-duodenal infusion of levodopa-carbidopa intestinal gel (LCIG) is a well-established therapy for patients with advanced Parkinson’s disease (PD) suffering from motor complications despite optimized treatment with oral dopaminomimetics. However, time to discontinuation of...

Descripción completa

Detalles Bibliográficos
Autores principales: Moes, Harmen R., Groenendal-Laurensse, Jerney W.M.J., Drent, Martje, Tissingh, Gerrit, van Laar, Teus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2020
Materias:
Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458507/
https://www.ncbi.nlm.nih.gov/pubmed/32675420
http://dx.doi.org/10.3233/JPD-201978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7458507/
https://www.ncbi.nlm.nih.gov/pubmed/32675420
http://dx.doi.org/10.3233/JPD-201978

Ejemplares similares